Discover 611 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 611
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
for
Cutaneous Lichen Planus
Location: Omaha NE, Overland Park KS, Indianapolis IN,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07775924
Phase 2, Recruiting
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
for
Common Warts (Verruca Vulgaris), Common Warts,
Location: Omaha NE, Tulsa OK, Plainfield IN, Clarkston MI,
Sponsor: Verrica Pharmaceuticals Inc.
Sex: All
Age: 2+
Code: NCT07457918
Phase 3, Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
for
Prurigo Nodularis (PN)
Location: Omaha NE, New Brighton MN, Indianapolis IN,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sex: All
Age: 18 - 70+
Code: NCT07236099
Phase 2, Recruiting
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
for
Hidradenitis Suppurativa
Location: Omaha NE, West Dundee IL, Fort Smith AR, Glenview IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07665437
Phase 3, Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Omaha NE, Skokie IL, Aurora CO, Indianapolis IN,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
for
Alopecia Areata
Location: Omaha NE, Saint Joseph MO, Chicago IL, Denver CO,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 12 - 17
Code: NCT07133308
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: Omaha NE, Overland Park KS, St Louis MO, Madison WI,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase 3, Recruiting
Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months
for
Respiratory Syncytial Virus (RSV)
Location: Omaha NE, Atlanta GA, San Antonio TX, Metairie LA,
Sponsor: Meissa Vaccines, Inc.
Sex: All
Age: 0 - 3
Code: NCT04909021
Phase 1, Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
for
Overweight or Obesity
Location: Omaha NE, Wichita KS, Oak Brook IL, Chicago IL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07685808
Phase 2, Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: Omaha NE, Lincoln NE, West Des Moines IA, Wichita KS,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: Omaha NE, Fremont NE, West Des Moines IA, Lenexa KS,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
Vocal Emotion Communication With Cochlear Implants
for
Cochlear Hearing Loss
Location: Omaha NE, Tempe AZ, Los Angeles CA
Sponsor: Father Flanagan's Boys' Home
Sex: All
Age: 6 - 70+
Code: NCT05486637
Early Phase 1, Recruiting
Reading Outcomes in Children With Vestibular Loss
for
Vestibular Disorder, Hearing Loss, Sensorineural
Location: Omaha NE
Sponsor: Father Flanagan's Boys' Home
Sex: All
Age: 7 - 18
Code: NCT05414903
Recruiting
Sentence Prediction in Developmental Language Disorder
for
Developmental Language Disorder
Location: Omaha NE
Sponsor: Father Flanagan's Boys' Home
Sex: All
Age: 5 - 7
Code: NCT07510854
Recruiting
New
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
for
Breast Cancer, Diabetes Type II
Location: Omaha NE, Grand Island NE, Atlanta GA, Morgantown WV,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07748208
Phase 2, Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for
Neuroendocrine Tumors Unresectable,
Location: Omaha NE, Iowa City IA, Rochester MN, St Louis MO,
Sponsor: Perspective Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05636618
Phase 1, Phase 2, Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
for
Prostate Cancer
Location: Omaha NE, Rochester MN, St Louis MO, Aurora CO,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05803941
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Omaha NE, Grand Island NE, Niles IL, Grand Rapids MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05139017
Phase 2, Phase 3, Recruiting
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Location: Omaha NE, St Louis MO, Chicago IL, Aurora CO,
Sponsor: Pathos AI, Inc.
Sex: Male
Age: 18+
Code: NCT06785636
Phase 1, Phase 2, Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Relapsed Diffuse Large B-cell Lymphoma,
Location: Omaha NE, Indianapolis IN, Toledo OH, Santa Fe NM,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)